#venture-capital

#venture-capital

Launching a fund used to be a real test of endurance, with timelines often stretching across many months. The process demanded patience that many ambitious founders found difficult to sustain.

Polymarket is reportedly in advanced talks to raise approximately $400 million in new funding at a post-money valuation of roughly $15 billion, according to a report published by The Information. The round has not been finalized, meaning terms could still change.

For most companies, there's roughly a 12-month period where the business is at its peak value, and then it crashes out. The companies that capture generational returns are often the ones where someone spies that moment instead of assuming the good times will get even better.

Cursor is nearing a funding round of at least $2 billion, with returning investors Thrive and Andreessen Horowitz expected to lead the financing at a $50 billion valuation. The deal terms are not final and may still change.

For decades, personalized financial guidance has been too expensive, too generic, or too hard to access. ChatGPT is finally changing that.

In March 2026, US startups raised $19.06 billion across 630 deals, a significant decline of 64.4% year-over-year from March 2025's $53.5 billion, which was heavily influenced by OpenAI's $40 billion mega-round.

Awards may be encouraging and occasionally useful for visibility, but they are weak indicators of validation and poor predictors of long-term success. In the longevity and healthspan industry, where timelines are long and claims are easy to overstate, venture capital ultimately follows alignment and evidence, not applause received at glitzy industry events.

Raising venture capital too early can cost you control, leverage and even your company. Early capital is often highly dilutive, selling off your future before your blueprint is complete. The difference between lighting a spark and burning your equity to ash is a lesson many founders learn too late.